Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
US9951389B2 · kind B2 · utility
1Cited by
40References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2015 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Oct 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.